British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

CA Lamb, NA Kennedy, T Raine, PA Hendy, PJ Smith… - Gut, 2019 - gut.bmj.com
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

Routine clinical markers of the magnitude of the systemic inflammatory response after elective operation: a systematic review

DG Watt, PG Horgan, DC McMillan - Surgery, 2015 - Elsevier
Background Operative injury to the body from all procedures causes a stereotypical cascade
of neuroendocrine, cytokine, myeloid, and acute phase responses. This response has been …

3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 2: surgical management and special situations

P Gionchetti, A Dignass, S Danese… - Journal of Crohn's …, 2017 - academic.oup.com
This paper is the second in a series of two publications relating to the European Crohn's and
Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management …

[HTML][HTML] ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious …

JW Baddley, F Cantini, D Goletti… - Clinical Microbiology …, 2018 - Elsevier
Background The present review is part of the ESCMID Study Group for Infections in
Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and …

Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: a meta-analysis of observational studies

W Huang, Y Tang, L Nong, Y Sun - Journal of Crohn's and Colitis, 2015 - academic.oup.com
Abstract Background and Aims: Postoperative intra-abdominal septic complications [IASCs]
are the most feared risks of surgery for Crohn's disease [CD]. The risk factors for IASCs still …

Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease

BL Cohen, DB Sachar - Bmj, 2017 - bmj.com
The treatment of inflammatory bowel disease (IBD)—ulcerative colitis (UC) and Crohn's
disease (CD)—has evolved beyond surgery with the introduction of biologic agents …

Postoperative complications after ileocecal resection in Crohn's disease: a prospective study from the REMIND group

M Fumery, P Seksik, C Auzolle… - Official journal of the …, 2017 - journals.lww.com
OBJECTIVES: We sought to determine the frequency of and risk factors for early (30-day)
postoperative complications after ileocecal resection in a well-characterized, prospective …

The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery

C Lau, M Dubinsky, G Melmed, E Vasiliauskas… - Annals of …, 2015 - journals.lww.com
Objective: Assess the impact of preoperative serum antitumor necrosis factor-α (anti-TNFα)
drug levels on 30-day postoperative morbidity in inflammatory bowel disease (IBD) patients …

Perioperative and postoperative management of patients with Crohn's disease and ulcerative colitis

EL Barnes, AL Lightner, M Regueiro - Clinical Gastroenterology and …, 2020 - Elsevier
Although the number of available therapies for the treatment of ulcerative colitis and Crohn's
disease (CD) continues to expand, a significant portion of patients with inflammatory bowel …

Meta‐analysis: peri‐operative anti‐TNF α treatment and post‐operative complications in patients with inflammatory bowel disease

N Narula, D Charleton… - Alimentary pharmacology & …, 2013 - Wiley Online Library
Background The impact of peri‐operative use of TNF α antagonists on post‐operative
complications such as infection and wound healing is controversial. Aim To conduct a …